Hostname: page-component-7c8c6479df-8mjnm Total loading time: 0 Render date: 2024-03-29T13:38:19.467Z Has data issue: false hasContentIssue false

[No Title]

Published online by Cambridge University Press:  03 January 2018

F. M. Quitkin
Affiliation:
New York State Psychiatric Institute, Office of Mental Health, 722 West 168th, Street, New York 10032, USA
D. F. Klein
Affiliation:
New York State Psychiatric Institute, Office of Mental Health, 722 West 168th, Street, New York 10032, USA
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Copyright
Copyright © 1998 The Royal College of Psychiatrists 

References

Daneman, E. A. (1961) Imipramine in office management of depressive reactions. Diseases of the Nervous System, 22, 213217.Google Scholar
Dimasi, J. A. (1995) Success rates for new drugs entering clinical testing in the United States. Clinical Pharmacology and Therapeutics, 58, 114.Google Scholar
Donovan, S. J., Quitkin, F. M., Stewart, J. S., et al (1994) Duration of antidepressant trials: clinical and research implicatons. Journal of Clinical Psychopharmacology, 14, 6466.CrossRefGoogle Scholar
Friedman, A. S. (1975) Interaction of drug therapy with marital therapy in depressive patients. Archives of General Psychiatry, 32, 619637.CrossRefGoogle ScholarPubMed
Friedman, A. S., Granick, S., Cohen, H. W., et al (1966) Imipramine (tofranil) vs. placebo in hospitalized psychotic depressives. Journal of Psychiatric Research, 4, 1336.CrossRefGoogle ScholarPubMed
Hollister, L. E., Overall, J. E., Johnson, M., et al (1964) Controlled comparison of imipramine, amitriptyline and placebo in hospitalized depressed patients. Journal of Nervous and Mental Disease, 139, 370375.CrossRefGoogle ScholarPubMed
Huttain, Z. (1970) Drugs in depressive illness. British Medical Journal, ii, 482.Google Scholar
Moncrieff, J., Wessely, S. & Hardy, R. (1998) Meta-analysis of trials comparing antidepressants with active placebos. British Journal of Psychiatry, 172, 227231.Google Scholar
Murphy, G. E., Simon, A. D. Wetzel, R. D., et al (1914) Cognitive therapy and pharmacotherapy. Archives of General Psychiatry, 41, 3341.Google Scholar
Quitkin, F. M., Rabkin, J. C., Ross, D., et al (1984) Duration of antidepressant drug treatment: What is an adequate trial? Archives of General Psychiatry, 41, 238245.Google Scholar
Ravaris, C. L., Nies, A., Robinson, E., et al (1976) A multiple dose controlled study of phenelzine in depression – anxiety states. Archives of General Psychiatry, 33, 347350.CrossRefGoogle ScholarPubMed
Simpson, G. M., Lee, J. H., Cuculica, A., et al (1976) Two dosages of imipramine in hospitalized endogenous and neurotic depressives. Archives of General Psychiatry, 33, 10931102.CrossRefGoogle ScholarPubMed
Tyrer, P., Garnder, M., Lambourn, J., et al (1980) Clinical and pharmacokinetic factors affecting response to phenelzine. British Journal of Psychiatry, 136, 359365.Google Scholar
Uhlenthuth, E. M. & Park, L. C. (1963) The influence of medication (imipramine) and doctor in relieving depressed psychoneurotic outpatients. Journal of Psychiatric Research, 2, 101122.CrossRefGoogle Scholar
Watt, D. C., Crammer, J. L. & Elkes, A. (1972) Metabolism, anticholinergic effects and therapeutic effects on outcome of desmethylimipramine in depressive illness. Psychological Medicine, 2, 397405.CrossRefGoogle ScholarPubMed
Weintraub, W. & Aronson, H. (1963) Clinical judgement in psychopharmacological research. Journal of Neuropsychiatry, 5, 6570.Google Scholar
Wilson, I. C., Vernon, J. T., Guin, T., et al (1961) A controlled study of treatments of depression. Journal of Neuropsychiatry, 4, 331337.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.